Medpace Holdings EBITDA 2014-2025 | MEDP
- Medpace Holdings EBITDA for the quarter ending March 31, 2025 was $0.120B, a 8.46% increase year-over-year.
- Medpace Holdings EBITDA for the twelve months ending March 31, 2025 was $0.486B, a 27.08% increase year-over-year.
- Medpace Holdings 2024 annual EBITDA was $0.476B, a 31.11% increase from 2023.
- Medpace Holdings 2023 annual EBITDA was $0.363B, a 20.63% increase from 2022.
- Medpace Holdings 2022 annual EBITDA was $0.301B, a 37% increase from 2021.
Medpace Holdings Annual EBITDA (Millions of US $) |
|
---|---|
2024 | $476 |
2023 | $363 |
2022 | $301 |
2021 | $220 |
2020 | $186 |
2019 | $151 |
2018 | $133 |
2017 | $103 |
2016 | $113 |
2015 | $93 |
2014 | $75 |
2013 | $91 |
Medpace Holdings Quarterly EBITDA (Millions of US $) |
|
---|---|
2025-03-31 | $120 |
2024-12-31 | $133 |
2024-09-30 | $120 |
2024-06-30 | $112 |
2024-03-31 | $111 |
2023-12-31 | $94 |
2023-09-30 | $92 |
2023-06-30 | $85 |
2023-03-31 | $92 |
2022-12-31 | $82 |
2022-09-30 | $84 |
2022-06-30 | $66 |
2022-03-31 | $69 |
2021-12-31 | $61 |
2021-09-30 | $59 |
2021-06-30 | $48 |
2021-03-31 | $53 |
2020-12-31 | $60 |
2020-09-30 | $51 |
2020-06-30 | $35 |
2020-03-31 | $40 |
2019-12-31 | $41 |
2019-09-30 | $35 |
2019-06-30 | $41 |
2019-03-31 | $34 |
2018-12-31 | $40 |
2018-09-30 | $30 |
2018-06-30 | $33 |
2018-03-31 | $30 |
2017-12-31 | $18 |
2017-09-30 | $29 |
2017-06-30 | $28 |
2017-03-31 | $28 |
2016-12-31 | $28 |
2016-09-30 | $28 |
2016-06-30 | $29 |
2016-03-31 | $28 |
2015-12-31 | |
2015-09-30 | $7 |
2014-12-31 | |
2013-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $9.228B | $2.109B |
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $143.921B | 26.99 |
Elevance Health (ELV) | United States | $89.416B | 11.54 |
CVS Health (CVS) | United States | $88.020B | 10.94 |
Cencora (COR) | United States | $57.242B | 19.91 |
DiDi Global (DIDIY) | China | $22.544B | 23.95 |
Labcorp Holdings (LH) | United States | $22.119B | 17.94 |
Natera (NTRA) | United States | $21.946B | 0.00 |
BioMerieux (BMXMF) | France | $16.861B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $14.094B | 0.00 |
Solventum (SOLV) | United States | $13.476B | 14.27 |
CochLear (CHEOY) | Australia | $12.827B | 0.00 |
ICON (ICLR) | Ireland | $12.023B | 11.18 |
Revvity (RVTY) | United States | $11.673B | 20.09 |
Viatris (VTRS) | United States | $10.774B | 3.70 |
Avantor (AVTR) | United States | $9.486B | 13.78 |
HealthEquity (HQY) | United States | $8.897B | 38.97 |
Sonic Healthcare (SKHHY) | Australia | $8.498B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.583B | 14.86 |
Caris Life Sciences,�Inc (CAI) | $6.744B | 0.00 | |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.758B | 28.02 |
BrightSpring Health Services (BTSG) | United States | $3.915B | 35.92 |
Sotera Health (SHC) | United States | $3.250B | 18.47 |
Surgery Partners (SGRY) | United States | $2.890B | 37.58 |
Alignment Healthcare (ALHC) | United States | $2.811B | 0.00 |
Concentras Parent (CON) | United States | $2.671B | 15.44 |
Organon (OGN) | United States | $2.613B | 2.78 |
GeneDx Holdings (WGS) | United States | $2.576B | 99.22 |
PACS (PACS) | United States | $1.974B | 0.00 |
Ardent Health (ARDT) | United States | $1.964B | 8.37 |
Progyny (PGNY) | United States | $1.891B | 41.62 |
Premier (PINC) | United States | $1.789B | 13.58 |
GoodRx Holdings (GDRX) | United States | $1.772B | 35.43 |
Teladoc Health (TDOC) | United States | $1.505B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.255B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.231B | 9.37 |
CareDx (CDNA) | United States | $1.050B | 16.39 |
Agilon Health (AGL) | United States | $0.985B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.842B | 7.88 |
QDM (QDMI) | Hong Kong, SAR China | $0.776B | 0.00 |
Nutex Health (NUTX) | United States | $0.732B | 11.09 |
Embecta (EMBC) | United States | $0.600B | 4.04 |
LifeMD (LFMD) | United States | $0.597B | 0.00 |
InnovAge Holding (INNV) | United States | $0.533B | 0.00 |
SBC Medicals (SBC) | United States | $0.483B | 0.00 |
Omada Health (OMDA) | $0.470B | 0.00 | |
Auna S.A (AUNA) | Luxembourg | $0.466B | 10.48 |
Sonida Senior Living (SNDA) | United States | $0.456B | 0.00 |
Enhabit (EHAB) | United States | $0.399B | 32.83 |
Performant Healthcare (PHLT) | United States | $0.322B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.296B | 0.00 |
So-Young (SY) | China | $0.288B | 0.00 |
Beauty Health (SKIN) | United States | $0.272B | 0.00 |
Oncology Institute (TOI) | United States | $0.196B | 0.00 |
DocGo (DCGO) | United States | $0.155B | 25.33 |
Pheton Holdings (PTHL) | China | $0.121B | 0.00 |
Sera Prognostics (SERA) | United States | $0.098B | 0.00 |
KindlyMD (NAKA) | United States | $0.082B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.066B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
ModivCare (MODV) | United States | $0.045B | 0.00 |
Biodesix (BDSX) | United States | $0.042B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.030B | 0.00 |
OSR Holdings (OSRH) | United States | $0.029B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.020B | 0.00 | |
Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |